Common-Size Income Statement
Quarterly Data
Based on: 10-Q (reporting date: 2026-09-27), 10-K (reporting date: 2026-06-28), 10-Q (reporting date: 2026-03-29), 10-Q (reporting date: 2025-12-28), 10-Q (reporting date: 2025-09-28), 10-K (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-Q (reporting date: 2024-12-29), 10-Q (reporting date: 2024-09-29), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-24), 10-Q (reporting date: 2023-09-24), 10-K (reporting date: 2023-06-25), 10-Q (reporting date: 2023-03-26), 10-Q (reporting date: 2022-12-25), 10-Q (reporting date: 2022-09-25), 10-K (reporting date: 2022-06-26), 10-Q (reporting date: 2022-03-27), 10-Q (reporting date: 2021-12-26), 10-Q (reporting date: 2021-09-26), 10-K (reporting date: 2021-06-27), 10-Q (reporting date: 2021-03-28), 10-Q (reporting date: 2020-12-27), 10-Q (reporting date: 2020-09-27).
The financial trajectory over the observed period is characterized by a significant expansion in profitability and a disciplined reduction in the cost of goods sold as a percentage of revenue. While a period of volatility and margin compression occurred in early 2023, the subsequent trend demonstrates a strong recovery and an overall improvement in operational efficiency.
- Gross Margin Performance
- Gross margins remained relatively stable between 45% and 47% from late 2020 through 2022. A notable contraction occurred in March 2023, where the margin reached a period low of 41.49%, coinciding with a spike in cost of goods sold to 58.51% and the introduction of restructuring charges. Following this trough, a sustained upward trend is observed, with gross margins consistently exceeding 50% from March 2025 onward, ultimately reaching 52.30% by September 2026.
- Operating Expense Trends
- Operating expenses exhibited fluctuating patterns, primarily driven by research and development (R&D) spending. R&D as a percentage of revenue dipped to a low of 8.54% in September 2022 before increasing to a peak of 13.50% in March 2024. In the final stages of the period, R&D spending decreased to 8.11%. Selling, general, and administrative (SG&A) expenses remained more stable, generally fluctuating between 4% and 6%, with a gradual decline toward 4.24% by the end of the period. Total operating expenses decreased from 17.16% in September 2020 to 12.35% in September 2026.
- Operating and Net Income
- Operating income demonstrates a strong recovery and growth pattern. After dipping to 24.35% in March 2023, operating margins climbed steadily, reaching 39.95% by September 2026. Net income followed a similar trajectory, recovering from a low of 21.04% in March 2023 to end the period at 33.50%. This growth in bottom-line profitability is primarily attributed to the combined effect of expanding gross margins and reduced operating expenses as a percentage of revenue.
- Non-Operating Items and Taxation
- Other income and expenses remained a relatively small component of the common-size statement, though they shifted from generally negative values in 2020-2021 to predominantly positive values through 2025. Income tax expense as a percentage of revenue showed significant volatility, ranging from a low of 1.14% in June 2025 to a peak of 6.80% in September 2026.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?